Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Edgewise Therapeutics Inc
EWTXCurrent price
13.45 USD
+0.47 USD (+3.62%)
Last closed
11.83 USD
Company
www.edgewisetx.com
ISIN
US28036F1057
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 414 146 432 USD
Yield for 12 month
-10.81 %
1Y
3Y
5Y
10Y
15Y
EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado. Address: 1715 38th Street, Boulder, CO, United States, 80301
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
42.78 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-1 732 000 USD
Current Quarter
+1 059 000 USD
Last Quarter
–
Key Figures EWTX
1 year
3 years
5 years
10 years
EBITDA
-156 763 008 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-24.01 %
PEG Ratio
–
Return On Equity TTM
-34.40 %
Wall Street Target Price
42.78 USD
Revenue TTM
–
Book Value
4.84 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.45 USD
Diluted Eps TTM
-1.45 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EWTX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History EWTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation EWTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.60
Price Book MRQ
3.08
Financials EWTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EWTX
For 52 weeks
10.60 USD
38.12 USD
50 Day MA
22.35 USD
Shares Short Prior Month
9 088 389
200 Day MA
25.18 USD
Short Ratio
6.80
Shares Short
10 387 232
Short Percent
15.91 %
BeatStart